cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Nautilus Biotechnology Inc
4 own
5 watching
Current Price
$2.73
$-0.1
(-3.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
379.8M
52-Week High
52-Week High
4.65000
52-Week Low
52-Week Low
1.78000
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization379.8M
icon52-Week High4.65000
icon52-Week Low1.78000
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio--
What does the Nautilus Biotechnology Inc do?
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Read More
How much money does Nautilus Biotechnology Inc make?
News & Events about Nautilus Biotechnology Inc.
Globe Newswire
11 months ago
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming B. Riley Securities Disruptive Biotech Enabling Technologies ...
Globe Newswire
12 months ago
SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming 43rd Annual Cowen Health Care Conference. Nautilus management is ...
Globe Newswire
1 year ago
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2022 before market open on Thursday, ...
Globe Newswire
1 year ago
Proteomics company opens new office in Southern California to facilitate ongoing research and team growth aimed at unlocking the potential of the proteome Nautilus Biotechnology - San Diego University Town Center in San Diego, California Nick Nelson SVP and Chief Business Officer SEATTLE, ...
Globe Newswire
1 year ago
Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus next-generation proteome analysis platform to advance the study of a rare childhood cancerSEATTLE, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company ...
Frequently Asked Questions
Frequently Asked Questions
What is Nautilus Biotechnology Inc share price today?
plus_minus_icon
Can Indians buy Nautilus Biotechnology Inc shares?
plus_minus_icon
How can I buy Nautilus Biotechnology Inc shares from India?
plus_minus_icon
Can Fractional shares of Nautilus Biotechnology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Nautilus Biotechnology Inc stocks?
plus_minus_icon
What is today’s traded volume of Nautilus Biotechnology Inc?
plus_minus_icon
What is today’s market capitalisation of Nautilus Biotechnology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Nautilus Biotechnology Inc?
plus_minus_icon
What percentage is Nautilus Biotechnology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Nautilus Biotechnology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.73
$-0.1
(-3.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00